Neil Kumar

CIK 1742485 · Chief Executive Officer · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$306.06M

Companies

2

Total Filings

79

Lifetime Open-Market Net

-$73.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BBIO Chief Executive Officer 4,581,774 $66.80 $306.06M -$145.07M 76 2026-06-08
Eidos Therapeutics, Inc. (EIDX) Delisted Chief Executive Officer 24,575,501 $72.01M 3 2019-07-08

Recent Filings · Page 3 of 8

79 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-08-11 BBIO Sell (S) −80,000 -$3.67M EDGAR
2025-07-03 BBIO Sell (S) −80,000 -$3.41M EDGAR
2025-05-20 BBIO Mixed −69,314 -$4.49M EDGAR
2025-04-24 BBIO Sell (S) −75,000 -$2.56M EDGAR
2025-03-27 BBIO Sell (S) −75,000 -$2.76M EDGAR
2025-03-21 BBIO Grant (A) $0 EDGAR
2025-02-27 BBIO Sell (S) −75,000 -$2.52M EDGAR
2025-02-19 BBIO Mixed -$1.98M EDGAR
2025-01-30 BBIO Sell (S) −600,000 -$21.79M EDGAR
2024-12-27 BBIO Gift (G) $0 EDGAR
Showing 2130 of 79
Page 3 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.